Test Roche Head Of Pharma Strategy Karsten Jung On Rebuilding The Portfolio
The Swiss pharma company is rebalancing the portfolio, emphasizing best-in-class drugs and moving into new areas like cardiovascular and metabolic disease.
Keep up with the top pharma business news of the week. On the go.
